Target Name: LOC105370455
NCBI ID: G105370455
Review Report on LOC105370455 Target / Biomarker Content of Review Report on LOC105370455 Target / Biomarker
LOC105370455
Other Name(s): Uncharacterized LOC105370455 | uncharacterized LOC105370455

LOC105370455: A Potential Drug Target and Biomarker

LOC105370455 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function and structure have been studied extensively, and it is known to play a critical role in several cellular processes. One of the most promising aspects of LOC105370455 is its potential as a drug target, which could lead to new treatments for a range of diseases. In this article, we will explore the potential of LOC105370455 as a drug target and biomarker.

The Importance of LOC105370455

LOC105370455 is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. It is a 21-kDa protein that is expressed in a variety of tissues, including the brain, heart, and kidneys. LOC105370455 is involved in several cellular processes, including the regulation of cell adhesion, the cytoskeleton, and the cell cycle.

One of the most promising aspects of LOC105370455 is its potential as a drug target. Its structure and function have been studied extensively, and it is known to play a critical role in several cellular processes. For example, LOC105370455 has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs.

In addition to its role in cell adhesion, LOC105370455 is also involved in the regulation of the cytoskeleton. The cytoskeleton is the structure that gives cells shape and provides support, and it is critical for the movement and function of cells. LOC105370455 is involved in the regulation of the cytoskeleton by the regulation of microtubules, which are the basic building blocks of the cytoskeleton.

Another promising aspect of LOC105370455 is its potential as a biomarker. Its expression is known to be associated with several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This suggests that LOC105370455 could be a useful biomarker for these diseases, and that its levels could be used to monitor the effectiveness of new treatments.

The Potential of LOC105370455 as a Drug Target

The potential of LOC105370455 as a drug target is its ability to interact with a variety of molecules and to regulate cellular processes that are important for the development and maintenance of tissues and organs. Its involvement in cell adhesion, the cytoskeleton, and the cell cycle make it an attractive target for drugs that are designed to modulate these processes.

One of the most promising aspects of LOC105370455 as a drug target is its involvement in the regulation of cell adhesion. The regulation of cell adhesion is critical for the development and maintenance of tissues and organs, and it is a process that is often targeted by drugs that are designed to modulate cell adhesion. LOC105370455 is involved in the regulation of cell adhesion by the regulation of microtubules, which are the basic building blocks of the cytoskeleton.

Another promising aspect of LOC105370455 as a drug target is its involvement in the regulation of the cytoskeleton. The cytoskeleton is the structure that gives cells shape and provides support, and it is

Protein Name: Uncharacterized LOC105370455

The "LOC105370455 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370455 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275 | LOC105371276 | LOC105371278 | LOC105371279 | LOC105371308 | LOC105371347 | LOC105371356 | LOC105371371 | LOC105371388 | LOC105371401 | LOC105371413 | LOC105371427 | LOC105371441 | LOC105371442 | LOC105371444 | LOC105371446 | LOC105371449 | LOC105371461 | LOC105371465 | LOC105371468 | LOC105371470 | LOC105371475 | LOC105371483